Authors:
KOLLERSTRAMETZ J
PACHER R
FREY B
KOS T
WOLOSZCZUK W
STANEK B
Citation: J. Kollerstrametz et al., CIRCULATING TUMOR-NECROSIS-FACTOR-ALPHA LEVELS IN CHRONIC HEART-FAILURE - RELATION TO ITS SOLUBLE RECEPTOR-II, INTERLEUKIN-6, AND NEUROHUMORAL VARIABLES, The Journal of heart and lung transplantation, 17(4), 1998, pp. 356-362
Authors:
HULSMANN M
STANEK B
FREY B
STURM B
PUTZ D
KOS T
BERGER R
WOLOSZCZUK W
MAURER G
PACHER R
Citation: M. Hulsmann et al., VALUE OF CARDIOPULMONARY EXERCISE TESTING AND BIG ENDOTHELIN PLASMA-LEVELS TO PREDICT SHORT-TERM PROGNOSIS OF PATIENTS WITH CHRONIC HEART-FAILURE, Journal of the American College of Cardiology, 32(6), 1998, pp. 1695-1700
Authors:
KOS T
PACHER R
WIMMER A
BOJIC A
HULSMANN M
FREY B
MAYER G
YILMAZ N
SKVARILOVA L
SPINAR J
VITOVEC J
TOMAN J
WOLOSZCUK W
STANEK B
Citation: T. Kos et al., RELATIONSHIP BETWEEN KIDNEY-FUNCTION, HEMODYNAMIC VARIABLES AND CIRCULATING BIG ENDOTHELIN LEVELS IN PATIENTS WITH SEVERE REFRACTORY HEART-FAILURE, Wiener Klinische Wochenschrift, 110(3), 1998, pp. 89-95
Authors:
WUTTE M
HULSMANN M
BERGER R
RODLER S
FREY B
STANEK B
PACHER R
Citation: M. Wutte et al., INTRAVENOUS PROSTAGLANDIN-E1 IMPROVES KIDNEY-FUNCTION IN PATIENTS WITH END-STAGE HEART-FAILURE, Wiener Klinische Wochenschrift, 110(13-14), 1998, pp. 473-478
Authors:
PACHER R
STANEK B
HULSMANN M
BOJIC A
BERGER R
FREY B
SIEGEL A
KOS T
OGRIS E
GRIMM M
LAUFER G
Citation: R. Pacher et al., PROSTAGLANDIN E-1 INFUSION COMPARED WITH PROSTACYCLIN INFUSION IN PATIENTS WITH REFRACTORY HEART-FAILURE - EFFECTS ON HEMODYNAMICS AND NEUROHUMORAL VARIABLES, The Journal of heart and lung transplantation, 16(8), 1997, pp. 878-881
Authors:
HULSMANN M
STANEK B
FREY B
BERGER R
RODLER S
SIEGEL A
HARTTER E
SCHULLER M
OGRIS E
PACHER R
Citation: M. Hulsmann et al., HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF LONG-TERM PROSTAGLANDIN E-1 INFUSIONS IN OUTPATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE, The Journal of heart and lung transplantation, 16(5), 1997, pp. 556-562
Authors:
PACHER R
STANEK B
HULSMANN M
BERGER R
SIEGEL A
DANESCHVAR H
RODLER S
FREY B
GRIMM M
LAUFER G
Citation: R. Pacher et al., PROSTAGLANDIN-E1 - BRIDGE TO CARDIAC TRANSPLANTATION - TECHNIQUE, DOSAGE, RESULTS, European heart journal, 18(2), 1997, pp. 318-329
Authors:
PACHER R
HULSMANN M
BERGER R
KOLLERSTRAMETZ J
KOS T
FREY B
DUKAT A
STANEK B
Citation: R. Pacher et al., EFFECTS OF ATENOLOL AS ADD-ON THERAPY TO FOSINOPRIL IN HEART-FAILURE, Wiener Klinische Wochenschrift, 109(7), 1997, pp. 232-238
Authors:
FREY B
HULSMANN M
BERGER R
ZUCKERMANN A
STANEK B
PACHER R
Citation: B. Frey et al., RIGHT-VENTRICULAR EJECTION FRACTION PREDICTS URGENT NEED FOR HEART-TRANSPLANTATION, Transplantation proceedings, 29(1-2), 1997, pp. 592-592
Authors:
STANEK B
FREY B
HULSMANN M
KOLLERSTRAMETZ J
HARTTER E
SCHULLER M
OGRIS E
MAURER G
PACHER R
Citation: B. Stanek et al., VALIDATION OF BIG ENDOTHELIN PLASMA-LEVELS COMPARED WITH ESTABLISHED NEUROHUMORAL MARKERS IN PATIENTS WITH SEVERE CHRONIC HEART-FAILURE, Transplantation proceedings, 29(1-2), 1997, pp. 595-596
Citation: B. Stanek et R. Pacher, DOSE-EFFECT RELATIONSHIPS OF PROSTAGLANDIN-E1 IN SEVERE END-STAGE CHRONIC HEART-FAILURE, Japanese Heart Journal, 38(1), 1997, pp. 53-65
Authors:
FREY B
DUKAT A
SAUERMANN S
HULSMANN M
BERGER R
STANEK B
PACHER R
Citation: B. Frey et al., EFFECTS OF ATENOLOL ON 24-HOUR HEART-RATE-VARIABILITY AND LEFT-VENTRICULAR FUNCTION IN HEART-FAILURE PATIENTS TREATED WITH HIGH-DOSE ANGIOTENSIN-CONVERTING ENZYME-INHIBITION, HEARTWEB, 2(1), 1996, pp. 105-111
Authors:
WUTTE M
HULSMANN M
BERGER R
SIEGEL A
STANEK B
PACHER R
Citation: M. Wutte et al., EFFECT OF PROSTAGLANDIN E(1) INFUSION ON KIDNEY-FUNCTION IN PATIENTS WITH SEVERE HEART-FAILURE, The Journal of heart and lung transplantation, 15(3), 1996, pp. 317-318
Authors:
PACHER R
STANEK B
HULSMANN M
KOLLERSTRAMETZ J
BERGER R
SCHULLER M
HARTTER E
OGRIS E
FREY B
HEINZ G
MAURER G
Citation: R. Pacher et al., PROGNOSTIC IMPACT OF BIG ENDOTHELIN-1 PLASMA-CONCENTRATIONS COMPARED WITH INVASIVE HEMODYNAMIC EVALUATION IN SEVERE HEART-FAILURE, Journal of the American College of Cardiology, 27(3), 1996, pp. 633-641
Authors:
PACHER R
STANEK B
GLOBITS S
BERGER R
HULSMANN M
WUTTE M
FREY B
SCHULLER M
HARTTER E
OGRIS E
Citation: R. Pacher et al., EFFECTS OF 2 DIFFERENT ENALAPRIL DOSAGES ON CLINICAL, HEMODYNAMIC ANDNEUROHUMORAL RESPONSE OF PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE, European heart journal, 17(8), 1996, pp. 1223-1232
Citation: R. Pacher et B. Stanek, PROSTAGLANDIN-E1 IN HEART-FAILURE - THE VIENNA EXPERIENCE, Wiener Klinische Wochenschrift, 108(16), 1996, pp. 491-495
Authors:
DANESCHVAR H
PACHER R
RODLER S
STANEK B
HULSMANN M
GRIMM M
LAUFER G
WOLNER E
BUNZEL B
Citation: H. Daneschvar et al., ACCEPTANCE OF A PUMP-DRIVEN INFUSION THERAPY WITH PROSTAGLANDIN E(1) AS A BRIDGE TO HEART-TRANSPLANTATION, Wiener Klinische Wochenschrift, 108(16), 1996, pp. 510-514
Authors:
FREY B
WUTTE M
BERGER R
IOANNIDES C
HULSMANN M
STANEK B
PACHER R
Citation: B. Frey et al., SUDDEN-DEATH AND STAGED THERAPY FOR HEMODYNAMIC STABILIZATION IN PATIENTS ENROLLED IN A HEART-TRANSPLANTATION PROGRAM, PACE, 18(1), 1995, pp. 152-158
Authors:
PACHER R
WUTTE M
GLOBITS S
DANESCHVAR H
BERGER R
RODLER S
BUHRINGER M
SCHMIDT S
HEINZ G
STANEK B
Citation: R. Pacher et al., AMBULATORY PUMP DRIVEN PROSTAGLANDIN-E1 INFUSION AS PHARMACOLOGICAL BRIDGING BEFORE HEART-TRANSPLANTATION IN REFRACTORY HEART-FAILURE, Journal of the American College of Cardiology, 1994, pp. 10000479-10000479